Currently Viewing:
Supplements Reducing the Risk of Cardiovascular Disease in Patients With Diabetes
Currently Reading
The Burden of Cardiovascular Disease in Patients with Diabetes
Brooke Hudspeth, PharmD, CDE
Economic Implications With Newer Agents to Reduce Cardiovascular Risk in Diabetes
Carrie McAdam-Marx, MSCI, PhD, RPh
Participating Faculty
Posttest

The Burden of Cardiovascular Disease in Patients with Diabetes

Brooke Hudspeth, PharmD, CDE
Adults with type 2 diabetes (T2D) have a 2-to-4–fold higher risk for cardiovascular morbidity and mortality than adults without diabetes, according to the American Heart Association (AHA). Furthermore, the AHA deems diabetes to be “1 of the 7 major controllable risk factors for cardiovascular disease (CVD).” Lack of glycemic control may lead to nerve and cardiac conduction impairments and CVD. However, glycemic control is not the only risk factor. Additional risk factors for CVD in T2D include hypertension, dyslipidemia, obesity, lack of physical activity, and smoking. Patients with T2D are also more likely to have risk factors that increase atherosclerotic cardiovascular disease (ASCVD) risk, including hypertension, dyslipidemia, and obesity. Control of these risk factors, as well as understanding the link between hyperglycemia and cardiovascular risk, is essential for the optimal management of T2D.
Am J Manag Care. 2018;24:-S0

Become a Member to see the rest of this article and get access to all of our articles and resources. Membership is Free!

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!